- Home
- CUE vs AIFF Comparison
CUE vs AIFF Comparison
Compare CUE & AIFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- AIFF
- Stock Information
- Founded
- CUE 2014
- AIFF 2006
- Country
- CUE United States
- AIFF United States
- Employees
- CUE N/A
- AIFF N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- AIFF
- Sector
- CUE Health Care
- AIFF
- Exchange
- CUE Nasdaq
- AIFF NYSE
- Market Cap
- CUE 48.0M
- AIFF 41.5M
- IPO Year
- CUE 2018
- AIFF N/A
- Fundamental
- Price
- CUE $0.70
- AIFF $2.74
- Analyst Decision
- CUE Strong Buy
- AIFF
- Analyst Count
- CUE 3
- AIFF 0
- Target Price
- CUE $3.00
- AIFF N/A
- AVG Volume (30 Days)
- CUE 220.4K
- AIFF 1.4M
- Earning Date
- CUE 08-13-2025
- AIFF 08-18-2025
- Dividend Yield
- CUE N/A
- AIFF N/A
- EPS Growth
- CUE N/A
- AIFF N/A
- EPS
- CUE N/A
- AIFF N/A
- Revenue
- CUE $7,991,000.00
- AIFF $139,000.00
- Revenue This Year
- CUE N/A
- AIFF N/A
- Revenue Next Year
- CUE $23.84
- AIFF N/A
- P/E Ratio
- CUE N/A
- AIFF N/A
- Revenue Growth
- CUE 13.83
- AIFF N/A
- 52 Week Low
- CUE $0.45
- AIFF $1.86
- 52 Week High
- CUE $1.99
- AIFF $17.20
- Technical
- Relative Strength Index (RSI)
- CUE 55.84
- AIFF 36.25
- Support Level
- CUE $0.54
- AIFF $3.03
- Resistance Level
- CUE $0.66
- AIFF $3.21
- Average True Range (ATR)
- CUE 0.06
- AIFF 0.25
- MACD
- CUE 0.01
- AIFF -0.04
- Stochastic Oscillator
- CUE 81.98
- AIFF 3.74
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The Company has one reportable segment: the BNA platform. The Company derives revenue from North America.